These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6887984)

  • 1. Model determination for use in automated control of drug dosages: application to d-tubocurarine.
    Bradlow HS; Sherlock BG; Thornington RE; Solomon ES
    Med Biol Eng Comput; 1983 Mar; 21(2):119-27. PubMed ID: 6887984
    [No Abstract]   [Full Text] [Related]  

  • 2. Vecuronium and d-tubocurarine combination: potentiation of effect.
    Mirakhur RK; Gibson FM; Ferres CJ
    Anesth Analg; 1985 Jul; 64(7):711-4. PubMed ID: 2861763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of pancuronium and metocurine: neuromuscular and hemodynamic advantages over pancuronium alone.
    Lebowitz PW; Ramsey FM; Savarese JJ; Ali HH; deBros FM
    Anesth Analg; 1981 Jan; 60(1):12-7. PubMed ID: 7192943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of neuromuscular blockade in man produced by combinations of pancuronium and metocurine or pancuronium and d-tubocurarine.
    Lebowitz PW; Ramsey FM; Savarese JJ; Ali HH
    Anesth Analg; 1980 Aug; 59(8):604-9. PubMed ID: 7190795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time course of muscle relaxation with a combination of pancuronium and tubocurarine.
    Mirakhur RK; Pandit SK; Ferres CJ; Gibson FM
    Anesth Analg; 1984 Apr; 63(4):437-40. PubMed ID: 6703370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromuscular blocking agents in burn patients.
    Thompson DF
    DICP; 1989 Dec; 23(12):1006-8. PubMed ID: 2603439
    [No Abstract]   [Full Text] [Related]  

  • 7. Dose requirement of d-tubocurarine and metocurine used for chronic respiratory paralysis in neonates.
    Nussmeier N; Henry GW; Stevens DC; Schreiner RL; Grosfeld JL
    J Pediatr Surg; 1981 Oct; 16(5):700-3. PubMed ID: 7310604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative examination of the interaction of competitive neuromuscular blocking agents on the indirectly elicited muscle twitch.
    Waud BE; Waud DR
    Anesthesiology; 1984 Oct; 61(4):420-7. PubMed ID: 6486503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamics of vecuronium, atracurium, tubocurarine and their combinations in the rat in vivo.
    Booij LH; van Egmond J; van de Pol F; Crul JF
    Eur J Anaesthesiol; 1985 Sep; 2(3):279-84. PubMed ID: 2866094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosage-schedule independence of d-tubocurarine pharmacokinetics and pharmacodynamics, and recovery of neuromuscular function.
    Ham J; Miller RD; Sheiner LB; Matteo RS
    Anesthesiology; 1979 Jun; 50(6):528-33. PubMed ID: 453578
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuromuscular blocking actions of the aminoglycoside antibiotics sisomicin and micronomicin in the rabbit.
    Matsukawa S; Suh JH; Hashimoto Y; Kato M; Satoh D; Saito S; Endo K; Saishu T
    Tohoku J Exp Med; 1997 Apr; 181(4):471-3. PubMed ID: 9210254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Criteria for use of pancuronium bromide, vecuronium bromide, atracurium besylate, tubocurarine chloride, metocurine iodide, pipecuronium bromide, and doxacurium chloride in adults.
    Donnelly AJ; Golembiewski JA; Skupski R; Wojtynek JE
    Clin Pharm; 1992 May; 11(5):435-41. PubMed ID: 1349856
    [No Abstract]   [Full Text] [Related]  

  • 13. What Is the Time to Muscle Relaxation After Intramuscular Administration of Neuromuscular Blockers?
    Shaw I; Trueger NS; Pirotte MJ
    Ann Emerg Med; 2015 Oct; 66(4):390-3. PubMed ID: 25964083
    [No Abstract]   [Full Text] [Related]  

  • 14. Decreasing enflurane concentrations and d-tubocurarine neuromuscular blockade.
    Gencarelli PJ; Miller RD; Eger EI; Newfield P
    Anesthesiology; 1982 Mar; 56(3):192-4. PubMed ID: 7059028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased d-tubocurarine requirement following major thermal injury.
    Martyn JA; Szyfelbein SK; Ali HH; Matteo RS; Savarese JJ
    Anesthesiology; 1980 Apr; 52(4):352-5. PubMed ID: 7362055
    [No Abstract]   [Full Text] [Related]  

  • 16. Proposed use of different posttetanic stimuli for assessment of profound surgical muscle relaxation.
    Gyermek L
    J Clin Monit; 1986 Jul; 2(3):211-3. PubMed ID: 3746373
    [No Abstract]   [Full Text] [Related]  

  • 17. Online control of d-tubocurarine induced muscle relaxation: a simulation study.
    Rametti LB; Bradlow HS
    Med Biol Eng Comput; 1983 Nov; 21(6):710-7. PubMed ID: 6664132
    [No Abstract]   [Full Text] [Related]  

  • 18. Intradermal histamine release by 3 muscle relaxants.
    Robertson EN; Booij LH; Fragen RJ; Crul JF
    Acta Anaesthesiol Scand; 1983 Jun; 27(3):203-5. PubMed ID: 6192671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Galanthamine as an antagonist of succinylcholine and tubocurarine in cancer patients].
    Gadalov VP; Khmelevskiĭ IaM
    Vestn Akad Med Nauk SSSR; 1974; (12):13-9. PubMed ID: 4446704
    [No Abstract]   [Full Text] [Related]  

  • 20. Kinetics of the elimination and neuromuscular blocking effect of d-tubocurarine in man.
    Gibaldi M; Levy G; Hayton W
    Anesthesiology; 1972 Mar; 36(3):213-8. PubMed ID: 5011414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.